KELLY FEE: Open Payments
NPI 1831478742 · SAN CLEMENTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 29 payments from 11 companies in 2025. Trend: 2023 $547 · 2024 $1,022 · 2025 $632
Food & beverage: $632
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $147 |
| ABBVIE INC. | 4 | $94 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| PFIZER INC. | 4 | $69 |
| Exact Sciences Corporation | 2 | $55 |
| Bausch Health US, LLC | 2 | $48 |
| Amgen Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $36 |
| Corcept Therapeutics | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: Wegovy, AIRSUPRA, UBRELVY, Cologuard Collection Kit, WELLBUTRIN, Ozempic, PREVNAR 20, QULIPTA.
Industry payments across CA — which companies pay providers there.
